Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Telomolecular Acquires Anti-Aging Technology from Stanford University

Abstract:
Telomolecular Corporation acquires an important technology from Stanford University that might be used to fight presently incurable problems of human aging and disease.

Telomolecular Acquires Anti-Aging Technology from Stanford University

Rancho Cordova, CA | Posted on May 22nd, 2007

Telomolecular Corporation, a Rancho Cordova based nanotechnology company, recently acquired a new technology from Stanford Leland Jr. University. The technology, called Mitofusin 1, allows for the repair of damaged mitochondrial DNA. Damage to mitochondrial DNA leads to forms of aging and a variety of diseases. By combining this tool with other portfolio products Telomolecular hopes to reverse certain symptoms and signs of human aging.

The terms of the agreement require that Telomolecular meet certain milestones in order to maintain permanent and exclusive worldwide licensing rights. The University is entitled to a royalty on goods as well as certain undisclosed fees.

This is really the first practical tool that can be used to repair damage to mitochondrial DNA. We believe that this acquisition reinforces our broader initiatives in the field of human aging and diversifies our ability to treat serious problems of age-associated disease. Mitofusin 1 represents an innovation in human health.

Mitochondria produce energy for the human body and play a role in human aging. The dysfunction of various mitochondrial genes have long been implicated in a number of rare diseases, some fatal. Mitochondria may also play a role in other, more common, diseases as well. Parkinson's disease, progressive-blindness diseases and certain cancers have been found to involve mutations in mitochondrial genes. Mitochondrial genes have also been implicated in type 2 diabetes in individuals who have none of the typical diabetes risk factors.

The correction of damaged mitochondrial DNA may have applications in human aging. An unfortunate side effect of aerobic respiration in mitochondria is that unstable molecules called reactive oxygen species (ROS) begin to accumulate in the mitochondrial DNA compartment and cause damage to mitochondrial DNA. The intentional mutation of mitochondrial DNA in lab animals causes premature aging (Larrson et al., 2004).
Additionally, mitochondrial DNA mutations are found to accumulate with age in humans.

According to the company's Chief Executive Officer, Matthew A. Sarad, "This is really the first practical tool that can be used to repair damage to mitochondrial DNA. We believe that this acquisition reinforces our broader initiatives in the field of human aging and diversifies our ability to treat serious problems of age-associated disease. Mitofusin 1 represents an innovation in human health."

####

About Telomolecular Corporation
Telomolecular develops nanotechnologies that treat problems of human aging. The corporation's primary focus is on the transport of therapeutic agents that lengthen and repair chromosomal telomeres in living animals. Successful therapies based on this tactic may offset, and potentially reverse, many devastating age-related diseases and perhaps address many symptoms and signs associated with human aging.

For more information, please click here

Contacts:
Matthew A. Sarad
msarad @ telomolecular.com
(916) 851-0271

Copyright © PRWeb™

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Announcements

New solar power material converts 90 percent of captured light into heat: SunShot Project aims to make solar cost competitive October 29th, 2014

Tiny carbon nanotube pores make big impact October 29th, 2014

Microrockets fueled by water neutralize chemical and biological warfare agents October 29th, 2014

Nanosafety research – there’s room for improvement October 29th, 2014

Patents/IP/Tech Transfer/Licensing

Lomiko Signs Licensing Agreement to Produce and Supply Power Converter Systems to E-Commerce Customers October 29th, 2014

Researchers patent a nanofluid that improves heat conductivity October 22nd, 2014

Nanodevices for clinical diagnostic with potential for the international market: The development is based on optical principles and provides precision and allows saving vital time for the patient October 15th, 2014

Aculon Receives Patent for Application of Enhanced Bonding Layers on Titanium October 9th, 2014

Human Interest/Art

Iran-Made Respiratory Nano Masks Provided to Hajj Pilgrims October 23rd, 2014

Japanese gold leaf artists worked on a nano-scale: Study demonstrates X-ray fluorescence spectroscopy is a non-destructive way to date artwork July 3rd, 2014

Harry Potter-style invisibility cloaks: A real possibility next Christmas? Forget socks and shaving foam, the big kids of tomorrow want an invisible cloak for Christmas December 19th, 2013

Chicago Awareness Organization First Not-for-Profit to Sponsor Dog Training to Detect Ovarian Cancer Odorants December 12th, 2013

Life Extension/Cryonics

RF Heating of Magnetic Nanoparticles Improves the Thawing of Cryopreserved Biomaterials October 23rd, 2014

Conceptual Nanomedical Lipofuscin Removal Strategy April 29th, 2013

utsandiego.com November 22nd, 2012

Nanoparticles against aging October 3rd, 2012

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE